WHO Grade 4 Glioma — Trials

WHO Grade 4 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,854 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 535
Recruiting: 286
Ph III recruiting: 15
Growth YoY: +41.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07515924	Oral Gallium Maltolate for Recurrent Glioblastoma	not yet recruiting	Early Phase 1	8	Medical College of WisconsinOTHER	1	Sep 23, 2026	clinicaltrials
NCT07781852	Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer	not yet recruiting	Early Phase 1	40	Lumina Pharmaceuticals IncINDUSTRY	1	Aug 28, 2026	clinicaltrials